← FDA DRUG APPROVALS

FDA ANDA · ANDA089775

ROXICET 5/500

Sponsor: ROXANE

APPLICATION
ANDA089775
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-12
LATEST ACTION
2001-06-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ROXICET 5/500Discontinued
ACETAMINOPHEN 500MG, OXYCODONE HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2001-06-01Labeling · Supplement 10AP
1999-04-13Manufacturing (CMC) · Supplement 9AP
1996-08-28Manufacturing (CMC) · Supplement 8AP
1995-06-23Manufacturing (CMC) · Supplement 6AP
1995-06-23Manufacturing (CMC) · Supplement 7AP
1994-07-25Manufacturing (CMC) · Supplement 5AP
1992-05-07Labeling · Supplement 4AP
1989-05-15Manufacturing (CMC) · Supplement 2AP
1989-05-15Manufacturing (CMC) · Supplement 1AP
1989-01-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →